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Original StudieS
Background: Antibiotic treatment of childhood illnesses is common in India. 
In addition to contributing to antimicrobial resistance, antibiotics might result 
in increased susceptibility to diarrhea through interactions with the gastrointes-
tinal microbiota. Breast milk, which enriches the microbiota early in life, may 
increase the resilience of the microbiota against perturbations by antibiotics.
Methods: In a prospective observational cohort study, we assessed whether 
antibiotic exposures from birth to 6 months affected rates of diarrhea up to 
age 3 years among 465 children from Vellore, India. Adjusting for treatment 
indicators, we modeled diarrheal rates among children exposed and unex-
posed to antibiotics using negative binomial regression. We further assessed 
whether the effect of antibiotics on diarrheal rates was modified by exclu-
sive breastfeeding at 6 months.
Results: More than half of the children (n = 267, 57.4%) were given at least 
one course of antibiotics in the first 6 months of life. The adjusted relative 
incidence rate of diarrhea was 33% higher among children who received 
antibiotics under 6 months of age compared with those who did not (inci-
dence rate ratio: 1.33, 95% confidence interval: 1.12, 1.57). Children who 
were exclusively breastfed until 6 months of age did not have increased 
diarrheal rates following antibiotic use.
Conclusions: Antibiotic exposures early in life were associated with 
increased rates of diarrhea in early childhood. Exclusive breastfeeding 
might protect against this negative impact.
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(Pediatr Infect Dis J 2015;34:583–588)
Antibiotics are frequently used to treat childhood illnesses, espe-cially respiratory tract infections, otitis media and diarrhea. 
However, many of these infections are viral and/or self-limiting, 
such that antibiotics are not necessary.1–3 The overuse of antibi-
otics among children has been reported around the world,1,4,5 and 
antibiotic over-prescribing by primary care physicians6,7 in India is 
further compounded by the ability to purchase antibiotics over the 
counter without a prescription8 in spite of government regulations.9
Often, the primary rationale given for restricting antibi-
otic use is to slow the development of antimicrobial resistance.10,11 
However, recent evidence has suggested antibiotics may also have a 
direct negative impact on the patients prescribed the drugs, primarily 
through interactions with the gastrointestinal (GI) microbiota.11 The 
development of the GI microbiota in the first few months of life coin-
cides with a critical period of intestinal structure and immune system 
maturation.12–14 A healthy microbiota is important in the early life 
defense against GI infections by providing a barrier effect that inhib-
its the attachment and growth of pathogens.15,16 Antibiotics impact the 
diversity and composition of the GI microbiota, and some of these 
effects can persist long after treatment is completed,17,18 especially 
among infants.19–23 These exposures have been further associated 
with impaired GI functioning, intestinal inflammation, and increased 
intestinal permeability and risk of systemic infections.21,24,25
Given the potential negative impact of antibiotics on the 
developing microbiota, we assessed whether antibiotic exposure 
in the first 6 months of life affected subsequent rates of all-cause 
diarrhea from 6 months to 3 years of age in a birth cohort from Vel-
lore, India. We also explored the impact of exclusive breastfeeding, 
which may modify this effect given the beneficial role of breast 
milk on the microbiota.26–28
MATERIALS AND METHODS
We performed an analysis of data from a prospective obser-
vational cohort study of immune responses in cryptosporidiosis in 
497 children followed from birth to 3 years of age. The parent study 
population consisted of all children born in 4 geographically adja-
cent, semiurban slums of Vellore, in the state of Tamil Nadu, India, 
between April 2009 and May 2010. The study population, enroll-
ment strategy and data collection methods have been previously 
described.29 The study was approved by the Institutional Review 
Boards of the Christian Medical College, Vellore, India, Tufts Uni-
versity Health Sciences campus, Boston, USA and University of 
North Carolina-Chapel Hill, USA.
Briefly, baseline information on maternal demographic 
characteristics, socioeconomic indicators, health-seeking behav-
ior, environment, diet and characteristics of delivery were col-
lected within 45 days of birth. Fieldworkers visited households of 
all enrolled children twice per week until 3 years of age to collect 
information on incidence, duration and hospitalization for all ill-
nesses as well as specific severity and treatment details for reported 
diarrhea. Caregivers were asked specifically if any antibiotics were 
given for diarrhea (yes/no) and if so, to report the name of the 
antibiotic (available for 64.0% of antibiotic reports). Breastfeed-
ing history (exclusive, nonexclusive, none) was collected every 
2 weeks until breastfeeding was stopped completely. Height and 
weight were measured monthly at the study clinic. Antibiotic pre-
scriptions and corresponding diagnoses were also extracted from 
records at the physician-run study clinic that was established in the 
study area to provide free health care to study children.
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Data and Definitions
The main exposures were any antibiotic exposure in the first 
6 months of life and the total number of antibiotic courses in the 
first 6 months of life, both based on a combination of antibiotic 
prescriptions recorded in clinic records and caregiver-reported 
antibiotic treatment at birth and for diarrhea. We excluded all topi-
cal antibiotics (neosporin, neomycin, soframycin and gentian vio-
let). This clinical definition of antibiotic exposure was used in all 
primary analyses. Exclusive breastfeeding was defined according 
to the standard World Health Organization (WHO) definition30 as 
feeding with breast milk only with the exception of vitamins, min-
eral supplements and medicines (no liquid, semisolid or solid food).
Diarrhea outcomes were based on caregiver-reported diarrhea 
at twice-weekly home visits. Diarrhea was defined using the stand-
ard WHO definition as at least 3 loose or watery stools in a 24-hour 
period.31 A new episode was defined as diarrhea that occurred after 
at least 2 days of normal bowel movements. Rates of diarrhea after 6 
months of age per child were defined by the total number of incident 
episodes divided by the total time that child remained in the study. 
We excluded from person-time denominators days with diarrhea 
(when a child was not at risk of incident diarrhea, 0.3% of total per-
son-time from 6 months to 3 years), periods during which the child 
was unreachable (0.6% of person-time from 6 months to 3 years) 
and any time after loss to follow-up or death (8.2% of person-time). 
Because the proportion of missing data was less than 3% for all base-
line variables (see footnote in Table 1), we imputed the median values 
of variables for individuals with missing data.
Data Analysis
We used Poisson and negative binomial regression to model 
the rates of diarrhea from 6 months to 3 years of age. The negative 
binomial model was preferred over the Poisson model by likelihood 
ratio test (P < 0.0001) and was used in final analyses to correct for 
overdispersion.34 Crude and adjusted incidence rate ratios (IRRs) 
for diarrhea were estimated comparing children who were exposed 
to early life antibiotics with those who were not. Confounding vari-
ables were chosen by causal directed acyclic graph35 based on the 
substantive literature, and optimal variable coding was determined 
by likelihood ratio test (α = 0.1) and Akaike’s information criterion.
Using the causal directed acyclic graph, we identified the 
following demographic characteristics and measures of illness in 
the first 6 months for adjustment in the models: child sex, socio-
economic status based on the Kuppuswamy scale,32 maternal edu-
cation, household hygiene,33 household crowding, low birth weight 
(<2.5 kg), number of diarrhea episodes in first 6 months, total 
number of days with diarrhea in first 6 months, maximum Vesi-
kari score36 of any diarrhea episode in first 6 months, number of 
severe episodes in first 6 months (Vesikari ≥ 11), prolonged or per-
sistent diarrhea episode in first 6 months, hospitalization for diar-
rhea in the first 6 months, fever during diarrhea in first 6 months, 
dehydration during diarrhea in first 6 months, underweight [aver-
age weight-for-age Z score under 6 months of age <−2 standard 
deviations (SD) from the 2006 WHO growth reference37], stunting 
(average height-for-age Z score <−2 SD), wasting (average weight-
for-height Z score <−2 SD) in the first 6 months, any severe illness 
in first 6 months and number of other infections in first 6 months.
Effect Measure Modification
We assessed whether the effect of early life antibiotic exposure 
on diarrheal risk after 6 months was modified by exclusive breast-
feeding at 6 months of age or at first antibiotic exposure by report-
ing stratum-specific estimates and testing homogeneity by likelihood 
ratio test (α = 0.1). We further explored the role of breastfeeding by 
assessing the crude association between exclusive breastfeeding and 
antibiotic treatment (both any exposure under 6 months, using log-
risk regression, and age at first exposure, using log-transformed age 
with linear regression). We further assessed effect measure modifica-
tion by sex, Cesarean section birth, age at first diarrhea and growth 
status (underweight, stunted and wasted) in first 6 months.
Sensitivity Analyses
To assess potential misclassification of the exposure, we 
repeated main analyses with more restricted definitions of antibiotic 
exposure that included caregiver-reported antibiotics only if an anti-
biotic name was recorded. To determine if the effect of antibiotics on 
diarrheal rates differed by antibiotic type,38,39 we repeated analyses 
separately comparing children who exclusively received one of the 
most commonly used antibiotics, amoxicillin and cotrimoxazole, 
with children who received no antibiotics. We were unable to assess 
other major classes of antibiotics because few children received other 
drugs. We further assessed if the effect of antibiotics differed depend-
ing on (1) the indication for which antibiotic treatment was given; 
(2) the number of diarrhea episodes experienced in the first 6 months 
of life; and (3) the time period for diarrheal outcomes (6–18 months 
of age compared with 18–36 months).
RESULTS
We included 465 of 497 children in the parent cohort (93.6%) 
who remained in the study for more than 6 months and were there-
fore at risk for diarrhea after 6 months of age. An additional 11.8% 
of children were lost to follow-up over the remaining study period; 
21, 24 and 10 children dropped out before 1, 2 and 3 years of age, 
respectively. All person-time during which these children remained 
in the study was included in the analysis, and differential follow-up 
times were accounted for in the analytic models. Six children died 
after 6 months of age, and 2 of these deaths were associated with 
diarrhea. Two-thirds of children were of low socioeconomic status 
(n = 308, 66.2%, Table 1). Children living in crowded households 
with more than 4 people per room were common (n = 149, 32.0%), 
and approximately half of the mothers reported poor household 
hygiene (n = 221, 47.5%). By 6 months of age, most children had 
stopped exclusive breastfeeding (n = 394, 84.7%) and had their first 
episode of diarrhea (n = 300, 64.5%).
Rates of diarrhea were highest between 3 and 9 months of 
life, with crude incidence rates of 28.1 cases per 100 person-months 
among children aged 3–6 months and 30.3 cases per 100 person-
months among children aged 6–9 months. After 6 months of age, 
diarrhea rates decreased to an average rate of 13.4 cases per 100 
person-months from 6 months to 3 years, corresponding to a total 
of 1693 episodes, or an average of 3.6 episodes per child in that 
period. The median number of diarrhea episodes after 6 months of 
age was 2 (interquartile range: 1, 5; Fig. 1).
Antibiotic exposure in the first 6 months of life was com-
mon. More than half (n = 267, 57.4%) of children were given at 
least one course of antibiotics in the first 6 months (Table 1). At the 
study clinic, antibiotic prescriptions in this age group were most 
frequently associated with diagnoses for upper respiratory infec-
tions (n = 160, 36.5% of total prescriptions), acute gastroenteritis 
(including diarrhea; n = 111, 25.3%), lower respiratory infections 
(n = 71, 16.2%) and acute otitis media (n = 18, 4.1%). Almost all 
children (n = 415, 89.2%) also received antibiotics after 6 months of 
age, and children who were given antibiotics under 6 months were 
more likely to receive antibiotics after 6 months compared with 
children who were not given antibiotics under 6 months (Table 1).
Amoxicillin and sulfamethoxazole/trimethoprim (cotrimoxa-
zole) were the most commonly given antibiotics. Children were gen-
erally given amoxicillin for respiratory illnesses and cotrimoxazole 
for GI illnesses. Approximately one-third of children received either 
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or both of these antibiotics before 6 months of age. Less common 
antibiotic exposures were cefixime (4.3% of children received cefix-
ime under 6 months of age), fluoroquinolones (ciprofloxacin, nor-
floxacin and levofloxacin; 2.4%) and azithromycin (1.7%).
Effect of Antibiotics on Diarrheal Rates
Antibiotic exposure under 6 months of age was crudely asso-
ciated with an increase in diarrhea rates from 6 months to 3 years 
(Table 2). After multivariable adjustment, the relative incidence rate 
of diarrhea was 33% higher among children who had at least 1 course 
of antibiotics under 6 months of age compared with those who did 
not [IRR: 1.33, 95% confidence interval (CI): 1.12, 1.57]. There was 
no significant difference in the effect by the number of antibiotic 
courses received. Children who received 3 or more courses of anti-
biotics had a slightly lower relative increase compared with 1 or 2 
courses, though this estimate was less precise (Table 2).
Effect Measure Modification
The effect of early antibiotic exposure differed by exclu-
sive breastfeeding practices in the first 6 months of life (P for 
TABLE 1. Demographic Characteristics of 465 Children in a Birth Cohort in 
Vellore, Tamil Nadu, India 2009–2013
No Antibiotics 0–5 Months 
(n = 198)
Antibiotics 0–5 Months  
(n = 267)
No. of Children (%) No. of Children (%)
Household characteristics
  Socioeconomic status*
   Low 139 (70.2) 169 (63.3)
   Medium 56 (28.3) 93 (34.8)
   High 3 (1.5) 5 (1.9)
  Maternal education
   No formal education 71 (35.9) 99 (37.1)
   Primary/middle school 72 (36.4) 86 (32.2)
   Higher secondary school 50 (25.3) 73 (27.3)
   College/polytechnic/professional  
 school
5 (2.5) 9 (3.4)
   Poor household hygiene† 89 (45.0) 135 (50.6)
  Crowding
   Low (≤ 3 people/room) 39 (19.7) 96 (36.0)
   Medium (3.1–4 people/room) 90 (45.5) 91 (34.1)
   High (>4 people/room) 69 (34.9) 80 (30.0)
Child characteristics
  Sex of child
   Male 97 (49.0) 149 (55.8)
   Female 101 (51.0) 118 (44.2)
  Cesarean section 32 (16.2) 50 (18.7)
  Low birth weight‡ 36 (18.2) 42 (15.7)
  Baby kept in ICU at birth 10 (5.1) 23 (8.6)
  Antibiotics at birth‡ 0 12 (4.5)
  Age at first diarrhea
   <6 months 100 (50.5) 200 (74.9)
   6 months to 1 year 58 (29.3) 38 (14.2)
   >1 year 17 (8.6) 14 (5.2)
   No diarrhea 23 (11.6) 15 (5.6)
  Number of diarrhea episodes 0–5 months
   0 98 (49.5) 67 (25.1)
   1 52 (26.3) 75 (28.1)
   2 34 (17.2) 68 (25.5)
   3+ 14 (7.1) 57 (21.4)
  Age (months) at stopping exclusive  
breastfeeding (mean, SD)
4.0 (2.20) 3.9 (1.98)
  Age (months) at stopping all breast-
feeding (mean, SD)
16.8 (7.95) 16.7 (8.57)
  Underweight in first 6 months 50 (25.3) 74 (27.7)
  Stunted in first 6 months 34 (17.2) 67 (25.1)
  Wasted in first 6 months 34 (17.2) 38 (14.2)
  Antibiotic use in first 6 months
   1 – 135 (50.6)
   2 – 74 (27.7)
   3+ – 58 (21.7)
  Antibiotic use 6 months to 3 years
   1 23 (11.6) 16 (6.0)
   2 27 (13.6) 22 (8.2)
   3+ 118 (59.6) 209 (78.3)
*Socioeconomic status categories defined from the Kuppuswamy scale based on educational and occupational level of the 
family, house ownership, total number of rooms in the house and household possessions.32
†Poor household hygiene was based on a score of less than 12 on a scale developed from an assessment of water, food 
and personal hygiene.33
‡Seven missing values for low birth weight; 14 missing values for antibiotics at birth.
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heterogeneity = 0.003). Children who were exclusively breast-
fed until at least 6 months of age (n = 71) did not show an 
increase in diarrheal rates associated with antibiotic exposure 
(Table 3). Conversely, among children who had discontinued 
exclusive breastfeeding before 6 months (n = 394), any early 
antibiotic exposure was associated with a 48% relative increase 
in diarrheal rates (IRR: 1.48, 95% CI: 1.23, 1.78). Results were 
qualitatively similar when restricting to exclusive breastfeeding 
at the first antibiotic exposure: the relative increase in diarrheal 
rates among children who were exclusively breastfed at their 
first antibiotic exposure was less than that among children who 
were not exclusively breastfed at their first antibiotic exposure 
(not shown).
Although breastfeeding modified the effect of antibiotics, 
duration of exclusive breastfeeding was not crudely associated 
with antibiotic use in the first 6 months of life. Children who were 
exclusively breastfed until at least 6 months were equally likely to 
be exposed to early life antibiotics as children who stopped exclu-
sive breastfeeding before 6 months (crude risk ratio: 0.94, 95% CI: 
0.76, 1.15). There was also no crude linear relationship between 
age at stopping exclusive breastfeeding and age at first antibiotic 
use (β = −0.0000, 95% CI: −0.0013, 0.0012).
There was no evidence of effect measure modification 
of the impact of antibiotics on diarrheal rate by sex, Cesarean 




In an alternative definition of antibiotic exposure, we 
included caregiver-report only if an antibiotic was named. Adjusted 
effects were qualitatively similar, but slightly closer to the null, for 
both overall effects and effects stratified by exclusive breastfeeding.
Antibiotic Type
There were no differences in the effect on diarrheal rates 
by antibiotic drug type. A sufficient number of children received 
amoxicillin (n = 145) and cotrimoxazole (n = 158) for multivari-
ate analyses. The adjusted IRR comparing children exposed to only 
amoxicillin with children who received no antibiotics was 1.46 
(95% CI: 1.12, 1.90), which was similar to the rate ratio comparing 
children exposed to only cotrimoxazole with unexposed children: 
1.32 (95% CI: 1.04, 1.69).
Indication for Treatment, Number of Diarrhea Episodes 
and Time Period for Diarrheal Outcomes
There was no difference in the effect of antibiotics on diar-
rheal rates depending on the indicating illness for antibiotic treat-
ment. Children treated with antibiotics for only diarrheal and only 
non-diarrheal illnesses had similar increases in diarrhea rates after 6 
months of age. The effect was also the same regardless of the num-





TABLE 2. Estimated Effect of Antibiotic Exposure in the First 6 Months of Life on Incident Rates of Diarrhea From 6 
Months to 3 Years of Age Among 465 Children in a Birth Cohort in Vellore, Tamil Nadu, India 2009–2013
No. of Children Rate of Diarrhea*
Incidence Rate Ratio (95% CI)
Crude Adjusted†
Antibiotics <6 months No 198 10.1 1. 1.
Yes 267 15.9 1.58 (1.33, 1.88) 1.33 (1.12, 1.57)
Number of antibiotic courses 0 198 10.1 1. 1.
1 135 15.0 1.49 (1.22, 1.83) 1.36 (1.12, 1.64)
2 74 16.7 1.66 (1.30, 2.11) 1.35 (1.07, 1.70)
3+ 58 17.0 1.69 (1.28, 2.22) 1.17 (0.89, 1.55)
*Rate per 100 person-months.
†Incident rate ratio adjusted for covariates listed in the methods.
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the time period for diarrheal outcomes (6–18 months of age com-
pared with 18–36 months). Results for all sensitivity analyses are 
available to readers by email request to the corresponding author.
DISCUSSION
Our study provides the first evidence that antibiotic treat-
ment early in life is associated with increased rates of all-cause 
diarrhea from 6 months to 3 years of age, even when controlling 
for indications for treatment, such as illness burden and severity. 
Furthermore, we found that exclusive breastfeeding during antibi-
otic exposure may be protective against the effects of antibiotics 
because antibiotic exposure was not associated with increased diar-
rheal rates among children who were exclusively breastfed for at 
least the first 6 months of life.
The effect of antibiotic treatment on diarrheal risk may be 
mediated by a prolonged effect of the antibiotics on microbiota 
composition17 or through collateral effects on intestinal structure 
and function relating to inflammation, permeability and intestinal 
immunity.24,40 In this way, antibiotics could affect susceptibility to 
diarrhea due to diverse pathogen etiologies. The strong effect modi-
fication by exclusive breastfeeding may also be explained by inter-
actions with the microbiota. Bacteria, such as Lactobacillus, are pre-
sent in breast milk and are thought to be beneficial: in a randomized 
trial of a Lactobacillus strain present in breast milk, infants given the 
probiotic demonstrated reduced incidence of GI infections.28,41 The 
protective effect of breastfeeding suggests the microbiota enriched 
by breast milk may be more resistant to perturbations by antibiotics.
Antibiotic treatment in the first 6 months of life was com-
mon among study children (57.4%). In the US and UK, the pro-
portion of children treated under 6 months of age based on car-
egiver-report is reported to be lower, at approximately one third 
of children.42,43 Higher rates of antibiotic use in our study popula-
tion may be because of higher rates of infection, better capture of 
antibiotic prescriptions in clinic records and greater availability of 
antibiotics without prescriptions.
The main limitation of this study was potential under-ascer-
tainment of antibiotic exposures for antibiotics obtained outside of the 
study clinic for non-diarrheal illnesses. However, we expect almost 
all antibiotic exposures to be captured in clinic records because the 
study clinic was conveniently located in the residential area where 
study children lived and provided clinical care and medicines free of 
charge. High concordance between caregiver-reported and antibiotic 
prescriptions for diarrhea supports our assumption that most antibi-
otic exposures were recorded in clinic records (78% of antibiotic pre-
scriptions during diarrhea episodes were associated with caregiver-
reported antibiotic treatment). The validity of caregiver-reported 
antibiotics was supported in sensitivity analyses by consistent results 
when using a more restricted definition of antibiotic exposure that 
required caregivers to list an antibiotic name.
We also did not have information on the duration of antibi-
otic exposures. Length of therapy may be an important component 
of the effect of antibiotics on diarrheal risk given the potential for 
longer antibiotic exposure periods to have increased impact on the 
microbiota.17,18,38 Although we were unable to assess the potential 
dose–response relationship between duration of exposures and 
increased diarrheal rates, we do not expect that this more detailed 
information would alter our overall conclusions of an effect of anti-
biotics on diarrheal rates.
Although we cannot ensure the absence of confounding in 
this observational study, we have adjusted for detailed treatment 
indications associated with disease severity that also predict diar-
rheal risk. As well, because a clinical trial that randomized all anti-
biotic treatment in this setting would be unethical, we believe this 
evidence from a well-conducted prospective observational cohort 
study with good follow-up provides important preliminary evidence 
toward understanding the impact of antibiotics on diarrheal risk. 
Antibiotics are commonly given during infancy at a time in 
which the developing GI microbiota is most sensitive to perturba-
tions. Although these drugs are lifesaving and should be used for 
treatment when necessary, the possibility for antibiotics to increase 
risk of future diarrheal disease should be further explored and 
potentially considered when making treatment decisions.
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TABLE 3. Estimated Effect of Antibiotic Exposure in the First 6 Months of Life on Rates 
of Diarrhea From 6 Months to 3 Years of Age by Exclusive Breastfeeding at 6 Months of Age 
Among 465 Children in a Birth Cohort in Vellore, Tamil Nadu, India 2009–2013
No. of  
Children
Adjusted IRR*  
(95% CI)
Exclusively breastfed at 6 months (n = 71)
  Antibiotics <6 months No 28 1.
Yes 43 0.76 (0.50, 1.13)
  Number of antibiotic courses† 0 28 1.
1 20 0.73 (0.45, 1.19)
2+ 23 0.77 (0.48, 1.23)
Not exclusively breastfed at 6 months (n = 394)
  Antibiotics <6 months No 170 1.
Yes 224 1.48 (1.23, 1.78)
  Number of antibiotic courses† 0 170 1.
1 115 1.53 (1.24, 1.88)
2+ 109 1.42 (1.14, 1.77)
* Incident rate ratio adjusted for covariates listed in the methods.
† Categorization was reduced to 0, 1 and 2+ courses because of small sample size (reduced model is supported by Akaike’s infor-
mation criterion).
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